Q.
Is funding for the cancer project based solely on 'a theory?'
A. No,
the research on past and current animal studies showed remarkable results.
Q. Have any animal or human studies been done?
A. Yes
Q. Over
what period of time?
A. Several years.
Q. What was
the accreditation of the late Dr. Brown whose work will be continued through CHAI
Foundation?
A. The following is a précis of a twenty-three (23)
page Curriculum Vitae listing the credentials of the primary researcher as a medical
doctor, lecturer, and author.
M.D., University of Rochester; B.A. (Biology
& Chemistry), Syracuse University; M.S. (Microbiology), Syracuse University;
Ph.D. (Virology & Immunology), University of Kansas.
-
Academic
Honors:
-
Honors:
-
Fellow,
American Academy of Microbiology
-
Fellow,
American Public Health Association
-
Member,
(1967-1977) Scientific Advisory Council, Leukemia Research Foundation
-
Reviewer,
Grants, American Chemical Society (1979-1980)
-
Reviewer,
Grants (pollution & epidemiology) National Science Foundation (since 1978)
-
Board
Member/ Fellow, Chicago Health Research Foundation, (since 1980)
-
Awards:
-
Scholar,
Leukemia Society, Inc. ($150,000 award) 1965-1970
-
Pre-doctoral
Fellow, National Institutes of Health, National Cancer Institute (1955-1957)
-
Fellow,
American Cancer Society, Inc. (1960-1963)
-
Morris
L. Parker Award, Senior Faculty Research Award 1977
-
Honorary
Societies:
-
Listed
In:
-
Dictionary
of International Biography, Who's Who in America, Who's Who in the
-
Midwest,
International Biography, American Men of Science, Leaders in
Science, and Who's Who in the World.
-
He
authored 63 publications (articles), 71 abstracts, chapters in three books, and
seven invited papers.
Q. Where would the testing stage of the research be conducted?
A.
In California, to take advantage of the state's 30-day 'fast-tracking' law for
I.N.D.s (Investigational New Drug applications), originated for AIDS; or where
best.
Q. Under what premise?
A. That the modality shows
promising application for life extension--through tumor and/or pain reduction,
and/or eradication--in cancer patients, and possibly AIDS patients.
Q. How many mice would be needed for the animal tests to show both the
efficacy and non-toxicity of the serum?
A. 200
Q. How
soon could results be seen after injecting the test mice with the serum?
A. Approximately 3-4 months.
Q. What is the cost of these animal
studies (including making the serum, remuneration for the primary researcher and
two (2) assistants, the use of a laboratory and its utensils, secretarial help,
etc.)?
A. Approximately $308,600
Q. How many human
patients would then be needed for a trial test following the mice studies?
A. 50 - 100
Q. If 'positive results' are defined as an amelioration
or absence of pain, and/or a reduction or disappearance of tumor(s), what is the
minimum amount of time in which positive results are expected to be noted in these
patients?
A. 3 - 8 months.
Q. What is the maximum amount
of time in which positive results are expected to be seen in these patients?
A. 8 - 15 months
Q. What is the minimum percentage of patients
in which positive findings are expected to result?
A. 60%
Q. What is the maximum percentage of patients in which positive findings are
expected to result?
A. 85%
Q. What would be the approximate
costs for the studies on 50 – 100 patients?
A. Approximately $1,691,400
(Any necessary expansion of this research will initiate additional costs).
Home
| Our Grantee | Donations
| Volunteer | Q &
A's | Updates |Contact
Us
©
Copyright 2003 - 2009 - Chai Foundation, Inc. - All Rights Reserved
Website by - Homepage
Success, Inc.
|
